A combined ANXA2-NDRG1-STAT1 gene signature predicts response to chemoradiotherapy in cervical cancer

BACKGROUND: A better understanding of locally advanced cervical cancer (LACC) is mandatory for further improving the rates of disease control, since a significant proportion of patients still fail to respond or undergo relapse after concurrent chemoradiation treatment (CRT), and survival for these p...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Exp Clin Cancer Res
Auteurs principaux: Buttarelli, Marianna, Babini, Gabriele, Raspaglio, Giuseppina, Filippetti, Flavia, Battaglia, Alessandra, Ciucci, Alessandra, Ferrandina, Gabriella, Petrillo, Marco, Marino, Carmela, Mancuso, Mariateresa, Saran, Anna, Villani, Maria Elena, Desiderio, Angiola, D’Ambrosio, Chiara, Scaloni, Andrea, Scambia, Giovanni, Gallo, Daniela
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2019
Sujets:
Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6595690/
https://ncbi.nlm.nih.gov/pubmed/31242951
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-019-1268-y
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires